ITGB4 and neoplasm: As proof-of-concept for this therapeutic approach, antagonizing ITGB4 ́s interaction with laminin 5 with the ASC8 antibody strongly reduced tumor cell invasion, confirming the potential of ITGB4 as therapeutic target to block local invasion.